A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

Clinical trial NCT02476916 · COMPLETED

Trial details

NCT number: NCT02476916
Sponsor: Agios Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pyruvate Kinase Deficiency

Start date: 2015-06-26
Primary completion: 2017-05-08
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.